Clinical Trials Browser

OTHER × Carcinoma, Non-Small-Cell Lung × aumolertinib × Clear all

NCT06951464 2025-07-23

A Study of BL-B01D1 and Almonertinib in Patients With Resectable EGFR+ Stage II-IIIB NSCLC

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT06752408 2024-12-30

ANOTHER

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT06604689 2024-11-12

AI-guided Prognostication and Cranial Radiotherapy Optimization in EGFR-TKI-treated Non-small Cell Lung Cancer Patients With Baseline Brain Metastases

Carcinoma, Non-Small-Cell Lung

NCT04685070 2024-08-14

Neoadjuvant HS-10296 (Almonertinib) Therapy for Potential Resectable Stage III EGFR Mutation-Positive Non-small Cell Lung Cancer

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT06463171 2024-06-17

Phase II Trial of Almonertinib Plus Lastet for EGFR+ Non-small Cell Lung Cancer

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT06452433 2024-06-11

Gumarontinib Combined With 3rd EGFR-TKI in Patients With Non-small Cell Lung Cancer.

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT06300424 2024-04-17

NEOVADE

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT06185400 2023-12-29

RC48 Combined With EGFR or HER2 TKI for Locally Advanced or Metastatic NSCLC Patients With HER2 Alterations

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT04401059 2023-12-27

SELECT-2

Phase 4 Recruiting

Adenocarcinoma, Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT04755738 2021-09-05

MWA

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT04978753 2021-07-27

the Efficacy and Safety of Anlotinib Combined With Almonertinib in the First-line Treatment of Patients With Brain Metastases From EGFR Mutation-positive Non-small Cell Lung Cancer

Phase 2 Unknown

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT04952168 2021-07-07

Combination of Almonertinib and Concurrent Chemoradiotherapy in Unresectable Stage III NSCLC

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT04944069 2021-06-29

ATTRACT

Phase NA Unknown

Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

NCT04905550 2021-06-02

Almonertinib Combined With Cerebral Radiation Treat Brain Metastases From EGFR Positive NSCLC

Phase 2 Unknown

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT04636593 2021-01-12

A Phase 2 Trial of Almonertinib With Concurrent Radiotherapy in The Treatment of Local Advanced EGFR-mutant NSCLC

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Radiation Pneumonitis

NCT04500704 2020-08-05

ACROSS1

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung

NCT04500717 2020-08-05

ACROSS2

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung

NCT04455594 2020-07-02

ANSWER

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung